Alibaba Health Information Technology Limited
ALBBY · OTC
9/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Revenue | $2 | $16 | $8 | $14 |
| % Growth | -85.8% | 100% | -42.8% | – |
| Cost of Goods Sold | $2 | $12 | $6 | $11 |
| Gross Profit | $1 | $4 | $2 | $4 |
| % Margin | 25% | 23.9% | 23.9% | 24.8% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $0 | $3 | $1 | $2 |
| Sales & Mktg Exp. | $0 | $1 | $1 | $1 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $0 | $3 | $2 | $3 |
| Operating Income | $0 | $1 | $0 | $1 |
| % Margin | 6.7% | 4.2% | 4.2% | 5.5% |
| Other Income/Exp. Net | $0 | $0 | $0 | $0 |
| Pre-Tax Income | $0 | $1 | $0 | $1 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | $0 | $1 | $0 | $1 |
| % Margin | 7.6% | 4.1% | 4.1% | 5.4% |
| EPS | 0.22 | 0.82 | 0.41 | 0.96 |
| % Growth | -73.2% | 100% | -57.3% | – |
| EPS Diluted | 0.22 | 0.82 | 0.41 | 0.96 |
| Weighted Avg Shares Out | 1 | 1 | 1 | 1 |
| Weighted Avg Shares Out Dil | 1 | 1 | 1 | 1 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | $0 | $1 | $0 | $1 |
| % Margin | 8.8% | 4.3% | 4.3% | 5.5% |